JUNS
Jupiter Neurosciences, Inc. Common Stock
stockNASDAQ
At CloseNov 2, 2026 3:49:52 PM EST
2.34USD+14.146%(+0.29)31,754
Loading…
Loading…
3.05M
Healthcare
Biotechnology
HQ
Jupiter, FL, USA
Previous Close
$2.05
Beta
1.59
52-Week High
$105.00 2025-11-03
52-Week Low
$2.05 2026-10-30
SMA 50
$3.16
SMA 200
$20.55
Avg. Vol 10D
18,829
Avg. Vol 30D
70,146
Avg. Vol 90D
709,564
Relative Vol
0.44
1.32M
564,077
42.78%
38,578
6.84%
1.00
38%/62%
22.85%
18.44%
36.3700%
85,000
266
2,501
7,697
Nov 13, 2026 (10d)
Aug 7, 2026 · 1-for-75 (reverse)
-9.2M
-1,888.7
JUNS Profile
jupiter neurosciences, inc. is a clinical-stage drug platform company focused on treating neuroinflammation. our mission is to make a significant impact for patients and society through a safe and oral medication for alzheimer's disease and for people with rare diseases.
JUNS Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 2.86 | 2026-10-26 | -19.23% | 2.966 |
| 1M | 2.55 | 2026-10-02 | -9.41% | 3.570 |
| 3M | 7.50 | 2026-08-03 | -69.20% | 3.216 |
| 6M | 29.25 | 2026-05-01 | -92.10% | 1.222 |
| 1Y | 99.00 | 2025-11-03 | -97.67% | 1.590 |
| 2Y | 411.75 | 2024-12-03 | -99.44% | — |
JUNS Stock Summary
Jupiter Neurosciences, Inc. Common Stock (NASDAQ:JUNS) stock price today is $2.31, and today's volume is 31,104. JUNS is up 12.683% today. The 30 day average volume is 70,146. JUNS market cap is $3.05M with 1.32M shares outstanding.